Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 2-methylidenebut-3-enoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

44804-88-8

Post Buying Request

44804-88-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

44804-88-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 44804-88-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,4,8,0 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 44804-88:
(7*4)+(6*4)+(5*8)+(4*0)+(3*4)+(2*8)+(1*8)=128
128 % 10 = 8
So 44804-88-8 is a valid CAS Registry Number.

44804-88-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-methylidenebut-3-enoate

1.2 Other means of identification

Product number -
Other names 2-Methylene-3-butenoic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:44804-88-8 SDS

44804-88-8Relevant academic research and scientific papers

Part II. Development of novel colchicine-derived immunosuppressants with improved pharmacokinetic properties

Chang, Dong-Jo,Lee, Sujin,Jang, Jaebong,Suh, Young-Ger,Kim, Soon-Ok,Kim, Wan-Joo

, p. 6750 - 6755,6 (2012)

We have developed a new series of immunosuppressant with improved pharmacokinetic properties as the second-generation of colchicine analogs, which were designed based on the privileged structure derived from our previous work. In particular, we identified an analog (14), which exhibited a potent in vitro activity (IC50: 5 nM) in MLR and excellent in vivo efficacy in the Zymosan A-induced arthritis model, in the Carrageenan-induced edema model and in the local lymph node assay (LLNA). Analog 14 also revealed a good oral bioavailability (F: 67.3%) in BALB/c mice.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 44804-88-8